Oncology

5 Jan 2018

232
(61 votes)

Five Medical Records to Qualify For Virotherapy for Stomach Cancer

Chemo showed zero efficacy? Or maybe you or your family member have metastases? Now when you’re looking for alternative methods to treat stomach cancer, let’s dive deep into the basics of virotherapy, its success rates, cost, and options.

Virotherapy lies in healing solid tumours with the help of oncolytic viruses. One of the most prominent is Rigvir®, invented in Latvia in the mid-1950s. Now the virus is becoming widespread among cancer patients who prefer alternative medicine to conventional.

First clinical trials of Rigvir® date back to 1970s, and are still being conducted. The 5-year survival rate in patients diagnosed with stage 3 stomach cancer, who faced surgery, was 24-33%, compared to 47-60% for patients who got virotherapy treatment for stomach cancer. Patients reading this article also inquire about Rigvir for bladder cancer.

The first step you have to take is to collect these 5 documents in digital form for a team of Latvian professionals to provide their medical opinion on whether Rigvir® therapy can help you or not.

  • Cytology report
  • Biopsy (or pathology) report
  • CBC (complete blood count) + WBC (white blood cells) not older than 2 weeks
  • Radiology reports (actual images are not needed)
  • Blood biochemistry incl. ALT (alanine aminotransferase), creatinine, etc.

The assessment of your case is free of charge, and is administered by the team of cancer specialists including the Chief Oncologist of Latvia. Collecting the documents can be dragged out for several weeks, so you’d better gather them as soon as possible. Normally, the review of cases takes no longer than three business days and is forwarded to your email immediately.

What happens next?

Here's a quick overview of the basic therapy package:


We’ve tried to respond to all the questions which may arise. However, if we missed something, please click the button below and we’ll get back to you within the next 24 hours.

Patients who read this article also inquire about virotherapy for prostate cancer and virotherapy for kidney cancer.